BNP/CALL/MERCK & CO./105/0.1/16.01.26 | Market Closed - Börse Stuttgart 03:12:50 2024-07-05 EDT | ||
| 2.7 EUR | -0.74% |
|
| Current month | -13.74% | ||
| 1 month | -8.78% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 2.7 | -0.74% |
| 24-07-04 | 2.72 | -8.11% |
| 24-07-03 | 2.96 | +2.78% |
| 24-07-02 | 2.88 | +8.68% |
| 24-07-01 | 2.65 | -15.34% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 03:12 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| WKN | PC1LLZ |
| ISIN | DE000PC1LLZ7 |
| Date issued | 2023-12-11 |
| Strike | 105 $ |
| Maturity | 2026-01-16 (558 Days) |
| Parity | 10 : 1 |
| Emission price | 1.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.36 € |
|---|---|
| Lowest since issue | 1.31 € |
| Spread | 0.02 € |
| Spread % | 0.72% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4
USD
Average target price
142.7
USD
Spread / Average Target
+12.84%
- Stock Market
- Warrants
- Warrant
